The PennZone

  • Home
  • Business
  • Health
  • Technology
  • Non-profit
  • Financial
  • Services
  • Entertainment
  • Construction

CCHR Calls for Audit of Forced Psychiatric Drugging and Systemic Misdiagnosis
The PennZone/10313279

Trending...
  • T-TECH Partners with Japan USA Precision Tools for 2026 US Market Development of the New T-TECH 5-Axis QUICK MILL™
  • $80M+ Backlog as Florida Statewide Contract, Federal Wins, and Strategic Alliance Fuel Next Phase of AI-Driven Cybersecurity Growth: Cycurion $CYCU
  • Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates
CCHR is calling for a clinical and financial audit
Coercive mental health treatment endangers lives, drives up costs, and bypasses basic medical screening, watchdog group says.

LOS ANGELES - PennZone -- By CCHR International

The Citizens Commission on Human Rights International (CCHR) is calling for a clinical and financial audit of the U.S. mental health system, warning that plans to involuntarily commit individuals experiencing homelessness could worsen mortality rates while escalating healthcare costs. The group emphasizes that psychotropic drugs commonly used in psychiatric facilities carry serious—often fatal—risks, especially when administered without thorough medical screening.

While no federal agency tracks national mortality rates among people experiencing homelessness, studies estimate a death rate between 3% and 8%.[1] CCHR warns this could rise if individuals are forcibly institutionalized and prescribed high-risk antipsychotics—known to cause fatal conditions such as Neuroleptic Malignant Syndrome (NMS).

High doses of antipsychotics are associated with significantly increased mortality, especially in young adults.[2] NMS has a mortality rate of up to 10%, according to The Handbook of Clinical Neurology.[3] Symptoms include hyperthermia, muscle rigidity, delirium, and coma. An estimated 100,000 Americans have died from NMS.[4]

Another long-term risk is Tardive Dyskinesia (TD), a debilitating movement disorder that resembles Parkinson's disease and affects at least 25% of those taking antipsychotics.[5] TD can persist long after the drugs are discontinued.

With over 11 million Americans prescribed antipsychotics, this translates to approximately 2.75 million potentially suffering from TD and more than 1.1 million at risk of NMS.[6] "Drug-induced brain damage is being disguised as 'mental illness,'" Jan Eastgate, president of CCHR, stated. "Tragically, the homeless are likely to be targeted for these toxic treatments if hospitalized."

CCHR points to concerning practices in California, where psychiatric outreach teams  inject homeless individuals with long-acting antipsychotics—under the euphemism of "street medicine." These injections can remain active for weeks, with individuals unable to stop the drugs' effects.

A core concern is psychiatry's frequent failure to conduct adequate medical assessments before diagnosing and drugging. A landmark California study (1983–84) found 39% of individuals admitted to state psychiatric hospitals had undiagnosed physical illnesses. Medical staff often failed to identify these, highlighting systemic diagnostic failure.[7]

More on The PennZone
  • AI Real Estate Company Quietly Building a National Powerhouse: reAlpha Tech Corp. (N A S D A Q: AIRE)
  • Inkdnylon Expands National Uniform Embroidery Services
  • Appliance EMT Expands Appliance Repair Services to Portland, OR and Vancouver, WA
  • Next Week: The World's Best Young Pianists Arrive in Music City for the 2025 Nashville International Chopin Piano Competition
  • Revenue Optics Builds Out Its Dedicated Sales Recruiting Firm with Strategic Addition of Christine Schafer

The study led to the development of the Mental Health Medical Evaluation Field Manual, which provided a low-cost screening algorithm capable of detecting 90% of these medical issues. There is no evidence that the manual is still in use. CCHR is calling for it to be implemented nationwide.

"This one change—comprehensive physical exams—could dramatically reduce misdiagnosis, psychiatric hospitalizations, and iatrogenic harm," Eastgate said.

The Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) admits that medical conditions can mimic psychiatric symptoms and must be ruled out. Psychiatrists use the term anosognosia—an alleged inability to recognize one's illness—as a rationale for forced treatment.[8] There is no objective test to confirm this theory.

There are concerns about conflicts of interest in psychiatric diagnosis. Of the DSM-5 task force members, 69% had financial ties to pharmaceutical companies. They received $14.2 million—of which $8.4 million went to those determining criteria for drug-induced movement disorders like TD.[9]

Meanwhile, mental health spending continues to soar with little to no measurable improvement in public outcomes. Treatment is often significantly more expensive than general medical care.[10] In 2013, U.S. mental health costs reached $201 billion—more than cancer and heart disease. By 2022, that figure had ballooned to $329 billion—a 94% increase in less than a decade, while the population grew by only 6.4%.

The consequences extend beyond cost. Antidepressants—sometimes prescribed with antipsychotics—were implicated in 5,863 overdose deaths in 2022, a 226% increase since 2000.[11] They can also increase the risk of repeated suicide attempts by 50%.[12]

Psychiatric outcomes remain dismal. The U.S. has the highest suicide rate among developed countries and the second-highest drug-related death rate.[13] A third of individuals in psychiatric hospitals are re-admitted within a year,[14] and 31% are assaulted while institutionalized.[15]

CCHR urges policymakers to:
  • Implement medical screening protocols based on California's Medical Evaluation Field Manual. Implement physical exams and lab testing prior to all psychiatric diagnoses.
  • Redirect funding from psychiatric institutions toward supportive housing and general medical care.
  • Hold psychiatric facilities accountable for failing to diagnose physical conditions and causing preventable harm.

"We need to abolish coercive psychiatric powers and first examine the harm already being done—and how much it's costing lives and taxpayers," Eastgate concluded.

More on The PennZone
  • Hydrofast Elevates the Holiday Season: The C100 Countertop RO System Merges Smart Tech with Wellness for the Perfect Christmas Gift
  • Melospeech Inc. Accepts Nomination for HealthTech Startup of the Year
  • Flower City Tattoo Convention Draws Record Attendance in Rochester, NY
  • KIKO NATION TOKEN (Official Release)
  • Verb™ Presents Features Vanguard Personalized Indexing: Utilizing Advanced Tax-Loss Harvesting Technology

CCHR's co-founder, the late psychiatrist Dr. Thomas Szasz, stated: "There is neither justification nor need for involuntary psychiatric interventions…. All history teaches us to beware of benefactors who deprive their beneficiaries of liberty."

Founded in 1969 by the Church of Scientology and Prof. Szasz, CCHR is a non-profit mental health watchdog with chapters across six continents. Its mission is to expose and eradicate abuse in the mental health field and to restore human rights and dignity to mental health care.

Sources:

[1] "Homeless Mortality: The Facts," National Health Care for the Homeless Council, nhchc.org/homeless-mortality/

[2] "Antipsychotic Medications and Mortality in Children and Young Adults," JAMA Psychiatry, 2024; jamanetwork.com/journals/jamapsychiatry/fullarticle/2811866

[3] "Chapter 25 - The psychopharmacology of catatonia, neuroleptic malignant syndrome, akathisia, tardive dyskinesia, and dystonia," Handbook of Clinical Neurology, Vol 165, 2019, www.sciencedirect.com/science/article/abs/pii/B9780444640123000253

[4] Mad in America: Bad Science, Bad Medicine, and the Enduring Mistreatment of the Mentally Ill, (Perseus Publishing, New York, 2002), pp. 207-208

[5] Handbook of Clinical Neurology, Vol 165, 2019

[6] www.cchrint.org/psychiatric-drugs/people-taking-psychiatric-drugs/

[7] Lorrin M. Koran, M.D., Department of Psychiatry and Behavioral Sciences, MEDICAL EVALUATION FIELD MANUAL, Stanford, CA, 1991, pp. 3-4, 18. www.alternativementalhealth.com/medical-evaluation-field-manual/

[8] Thomas Szasz, MD, Coercion as Cure: A Critical History of Psychiatry, 2007, p. 22

[9] Lisa Congrove, et al., "Undisclosed financial conflicts of interest in DSM-5-TR: cross sectional analysis," BMJ, 10 Jan. 2024, www.bmj.com/content/384/bmj-2023-076902

[10] Melek, S., et al., "Addiction and mental health vs. physical health: Widening disparities in network use and provider reimbursement," Milliman Research Report, C, 20 Nov. 2019

[11] www.statista.com/statistics/895959/antidepressant-overdose-deaths-us/

[12] Peter Gøtzsche, MD, "So-Called Suicide Experts Recommend Antidepressants, Which Increase Suicides." 24 Oct. 2024, www.madinamerica.com/2024/10/so-called-suicide-experts-recommend-antidepressants-which-increase-suicides/

[13] www.commonwealthfund.org/publications/issue-briefs/2020/may/mental-health-conditions-substance-use-comparing-us-other-countries

[14] Owusu E, et al., "Readmission of Patients to Acute Psychiatric Hospitals: Influential Factors and Interventions to Reduce Psychiatric Readmission Rates," Healthcare (Basel), 2022 Sep 19;10(9), pmc.ncbi.nlm.nih.gov/articles/PMC9498532/

[15] "Fear, Neglect, Coercion, and Dehumanization: Is Inpatient Psychiatric Trauma Contributing to a Public Health Crisis?" Journal of Patient Experience, 9 Aug. 2022, journals.sagepub.com/doi/full/10.1177/23743735221079138

Contact
CCHR International
***@cchr.org


Source: Citizens Commission on Human Rights International
Filed Under: Health

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • African American Genealogy Group Launches 2025 Raffle Fundraiser to Support Legacy Research
  • Take Control of Your Color Matching with Boston Industrial Solutions' Newly Expanded Natron® UVPX Series Ink Colors
  • "Dr. Vincent Michael Malfitano Expands Monterey–Sicily Cultural Diplomacy With Major International Media Engagement"
  • Kaufman Development Breaks Ground on Detroit Micro Data Center, Expanding Its National AI Platform
  • Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates
  • $80M+ Backlog as Florida Statewide Contract, Federal Wins, and Strategic Alliance Fuel Next Phase of AI-Driven Cybersecurity Growth: Cycurion $CYCU
  • High-Conviction CNS Disruptor Aiming to Transform Suicidal Depression, Ketamine Therapeutics, and TMS - Reaching Millions by 2030
  • Top10Christmas.co.uk Releases the UK Christmas Toy Trends 2025 Report
  • Talagat Business Academy Announces Joint Certificate Program With The University of Chicago Booth School of Business
  • LocaXion and Asseco CEIT Announce First-to-Market RTLS-Driven Digital Twin Platform for Healthcare, Manufacturing, and Logistics
  • Slotozilla Launches New Report on How AI Is Reshaping Careers and Society
  • OKAVA Pharmaceuticals Announces First Cat Dosed in MEOW-1 Study of OKV-119, the World's First Clinical-Stage GLP-1 Weight-Loss Therapy for Pets
  • Explosive Growth in U.S. Cryptocurrency Cloud Mining Sets The Stage for New Platform Launch with Daily Rewards in a Transparent Revenue-Share Model
  • Qtex Cierra Ronda de $7 Millones para Estandarizar la Banca Transfronteriza en los Mercados Emergentes de Latinoamérica
  • Ring in the Season with Free Holiday Jazz from The Jazz Sanctuary
  • America's Most Festive Garages Wanted for Garage.com's 2025 Holiday Contest
  • FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough
  • BEC Technologies Expands MX-220 5G Industrial Router Series for Edge Connectivity
  • "Latino Leaders Speak: Personal Stories of Struggle and Triumph, Volume II" Documents the Truth About Latino Excellence and Impact on American Society
  • Broadway Smile Boutique Unveils Modern Website for Enhanced Patient Experience

Popular on PennZone

  • Liquidity Aggregation: US-Registered JHKXWL Integrates AI Analytics for Brazilian and Global Institutional Traders - 475
  • BumblebeeSmart Introduces Rounded Busy Board Set for Preschoolers - 189
  • Light Her Way Launches New Cohort of Board of AdviseHERS to Prepare Women for Board-Ready Leadership - 101
  • 5,000 Australians Call for Clarity: NaturismRE's Petition Reaches Major Milestone
  • Corcoran DeRonja Real Estate Welcomes Siobhán Simões to Its Growing Team
  • Heritage At Manalapan - A New Luxury Single Family Home Community Coming Late 2025
  • BITE Data raises $3m to build AI tools for global trade compliance teams
  • purelyIV Expands Wellness Services with Flu/COVID Testing and Menopause Coaching & Treatment
  • CCHR Supports Call to End Coercive Psychiatry at World Mental Health Congress
  • U.S. Entrepreneur Anjo De Heus Builds Innovation Bridge Between America and the Gulf

Similar on PennZone

  • Anderson Periodontal Wellness Attends 5th Joint Congress for Ceramic Implantology
  • Hydrofast Elevates the Holiday Season: The C100 Countertop RO System Merges Smart Tech with Wellness for the Perfect Christmas Gift
  • Melospeech Inc. Accepts Nomination for HealthTech Startup of the Year
  • From Cheer to Courtroom: The Hidden Legal Risks in Your Holiday Eggnog
  • T-TECH Partners with Japan USA Precision Tools for 2026 US Market Development of the New T-TECH 5-Axis QUICK MILL™
  • "Dr. Vincent Michael Malfitano Expands Monterey–Sicily Cultural Diplomacy With Major International Media Engagement"
  • Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates
  • High-Conviction CNS Disruptor Aiming to Transform Suicidal Depression, Ketamine Therapeutics, and TMS - Reaching Millions by 2030
  • Top10Christmas.co.uk Releases the UK Christmas Toy Trends 2025 Report
  • FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us